Splenic Irradiation-Induced Sweet’s Syndrome Associated with Preceding Myelofibrosis

Yue Che,Miki Tanioka,Yasuhiro Matsumura,Yosuke Miyachi
DOI: https://doi.org/10.1111/j.1365-2230.2007.02589.x
2008-01-01
Clinical and Experimental Dermatology
Abstract:Conflict of interest: none declared. Sweet's syndrome (SS) is also known as acute febrile neutrophilic dermatosis. Approximately 20% of patients with SS have an associated malignancy, with haematological malignancies accounting for the majority of these. A 70‐year‐old man presented with an 8‐year history of refractory myelofibrosis (MF) and was admitted for splenic irradiation, because he had ruptured oesophageal varices due to portal hypertension induced by splenomegaly. The irradiation (0.5 Gy for 5 days; total 2.5 Gy) was ceased because blood tests showed leucopenia. Two days after the last irradiation, localized erythema with tenderness was noticed on the patient's back. He had a fever, accompanied by chills and malaise. Painful nodules gradually developed over the whole body. Seven days after the first skin lesion developed, the patient received granulocyte colony‐stimulating factor (G‐CSF) injection once a day for 3 days to treat severe leucopenia. After the G‐CSF administration, the skin lesions rapidly increased.
What problem does this paper attempt to address?